ImmunOs Therapeutics
Team & Investors
Leadership, board of directors, and investment partners
Executives
0
Board Members
0
Investors
21
Total Funding
$104.5M
Investors
21 investors across all rounds
Explore More Data
Detailed analysis for ImmunOs Therapeutics
ImmunOs Therapeutics Leadership & Investors
ImmunOs Therapeutics is led by a team of experienced leaders. The company has attracted investment from 21 institutional and strategic investors.
Who Has Invested in ImmunOs Therapeutics?
ImmunOs Therapeutics has raised $104.5M from 21 investors including venture capital firms, private equity investors, and strategic partners.
Investment Opportunity
Accredited investors can access ImmunOs Therapeutics shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.